Home/Companies/CIK 0000719447
H
ISSUER//CIK 0000719447

HYCOR BIOMEDICAL INC /DE/

Exchange

Entity type

operating

Fiscal year end

Dec 31

Headquarters

DE

Research Summary

AI-assisted · Grounded in filings

Updated Nov 27, 2025

HYCOR BIOMEDICAL INC /DE/

HYCOR Biomedical Inc (CIK 719447) is a global diagnostic company specializing in in vitro diagnostic products for allergen-specific IgE allergy testing. Founded in 1981, the company manufactures and markets advanced diagnostic systems including its flagship NOVEOS Immunoassay Analyzer, serving clinical laboratories, hospitals, and physicians' offices worldwide. HYCOR targets healthcare providers requiring reliable allergy diagnostic testing solutions, holding approximately 5% market share in the allergy testing sector. The company faces material risks including intense competition from larger diagnostics manufacturers such as Thermo Fisher Scientific, product development and commercialization challenges, regulatory approval dependencies, and market adoption risks for new technologies. With operations in North America and Europe, HYCOR continues to focus on delivering innovative allergy diagnostic solutions to the medical community. Explore HYCOR Biomedical's latest SEC filings on Earnings Feed.